Advertisement


David Fajgenbaum, MD, MBA, on Repurposing Cancer Drugs to Treat COVID-19

AACR Virtual Meeting: COVID-19 and Cancer 2021

Advertisement

David Fajgenbaum, MD, MBA, of the University of Pennsylvania, talks about his research efforts to find an already-approved drug that could treat his orphan disease—multicentric Castleman disease—and how that methodology may be applied to the coronavirus and the cytokine storm it can cause (Symposium 5).



Related Videos

COVID-19

Antoni Ribas, MD, PhD, on Highlights of AACR’s COVID-19 and Cancer Meeting

Antoni Ribas, MD, PhD, of the University of California, Los Angeles and Jonsson Comprehensive Cancer Center, and President of the American Association for Cancer Research, ta...

COVID-19

Toni K. Choueiri, MD, on the Effects of Cancer Treatments on Patients Infected With COVID-19

Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discusses the challenges of delivering optimal cancer treatments in the face of the coronavirus pandemic. Focusing on s...

COVID-19

Giuseppe Curigliano, MD, PhD: In the Face of COVID, Continuity in Cancer Care

Giuseppe Curigliano, MD, PhD, of the University of Milan and Istituto Europeo Oncologico, talks about designing public health measures focused on COVID-19 morbidity and morta...

Advertisement

Advertisement



Advertisement